x

Search for a clinical trial

* (*) mandatory field

A Phase 2 Randomized, Double-Blind, Crossover, Controlled, Multi-Center Subject Preference Study of Tivozanib Hydrochloride Versus Sunitinib in the Treatment of Subjects With Metastatic Renal Cell Carcinoma - ES (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Astellas pharma global development, inc., Aveo pharmaceuticals, inc.
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - ES
  • ADDRESS: NOT PROVIDED - ES
  • SPAIN
  • More information
  • Phone  : 
    Information not provided - ES
  • Fax  : -
Last update: September 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.